Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.

Aimi, Fabio; Moch, Holger; Schraml, Peter; Hottiger, Michael O

Aimi, Fabio; Moch, Holger; Schraml, Peter; Hottiger, Michael O.

Afiliação

Aimi F; University of Zurich (UZH), Department of Molecular Mechanisms of Disease (DMMD), Zurich, Switzerland.
Moch H; University of Zurich and University Hospital Zurich (USZ), Department of Pathology and Molecular Pathology, Zürich, Switzerland.
Schraml P; University of Zurich and University Hospital Zurich (USZ), Department of Pathology and Molecular Pathology, Zürich, Switzerland.
Hottiger MO; University of Zurich and University Hospital Zurich (USZ), Department of Pathology and Molecular Pathology, Zürich, Switzerland.

Mod Pathol ; 34(8): 1468-1477, 2021 08.

Article em En | MEDLINE | ID: mdl-33742140

Assuntos

ADP-Ribosilação; Biomarcadores Tumorais/análise; Neoplasias/patologia; Citoplasma/metabolismo; Humanos; Imuno-Histoquímica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / ADP-Ribosilação / Neoplasias Limite: Humans Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google